Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: A putative marker of disease activity and progression in SPMS

Neuroradiology

Volumn 54, Issue 4, 2012, Pages 287-297

  Tian, Wei ^a   Zhu, Tong ^a   Zhong, Jianhui ^a   Liu, Xiang ^a   Rao, Praveen ^b   Segal, Benjamin M ^b   Ekholm, Sven ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Corpus callosum; Diffusion tensor imaging; DTI; Secondary progressive multiple sclerosis; SPMS

Indexed keywords

GADOLINIUM; LYMPHOTOXIN BETA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORPUS CALLOSUM; DETERIORATION; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; FRACTIONAL ANISOTROPY; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MALE; MEAN DIFFUSIVITY; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS;

ANALYSIS OF VARIANCE; ANISOTROPY; CASE-CONTROL STUDIES; CONTRAST MEDIA; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; STATISTICS, NONPARAMETRIC;

EID: 84862855007     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-011-0885-8     Document Type: Article

References (31)

1. Miller DH, Grossman RI, Reingold SC et al (1998) The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121:3-24 (Pubitemid 28045503)
2. Katz D, Taubenberger JK, Cannella B et al (1993) Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 34:661-669 (Pubitemid 23333237)
3. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey - National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46:907-911
4. Grossman RI, Braffman BH, Brorson JR et al (1988) Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 169:117-122
5. Fillippi M, Rossi P, Colombo B et al (1997) Serial contrastenhanced MR in patients with multiple sclerosis and varying levels of disability. AJNR 18:1549-1556 (Pubitemid 30413972)
6. Guo AC, Macfall JR, Provenzale JM et al (2002) Multiple sclerosis: diffusion tensor MR imaging for evaluation of normalappearing white matter. Radiology 222:729-736 (Pubitemid 34215221)
7. Werring DJ, Brassat D, Droogan AG et al (2000) The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 123:1667-1676 (Pubitemid 30481190)
8. Bammer R, Augustin M, Siegrid SF et al (2000) Magnetic resonance diffusion tensor imaging for characterization diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med 44:583-591
9. Ge Y, Law M, Johnson G et al (2004) Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging. J Magn Reson Imaging 20:1-7 (Pubitemid 38857510)
10. Ranjeva JP, Pelletier J, Gouny SC et al (2003) MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 9:554-565 (Pubitemid 37479403)
11. Hanson MK, Gupta KR, Santos MR (2005) Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. J Magn Reson Imaging 21:735-743
12. Oh J, Henry RG, Genain C (2004) Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1 H MRS imaging. J Neurol Neurosurg Psychiatry 75:1281-1286 (Pubitemid 39141333)
13. Lou X, Jiang WJ, Ma L et al (2009) Lower fractional anisotropy at the anterior body of the normal-appearing corpus callosum in multiple sclerosis versus symptomatic carotid occlusion. Neuroradiology 51:557-561
14. Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840-846 (Pubitemid 41746873)
15. Miller DH, Barkhof F, Berry I et al (1991) Magnetic resonance imaging in the monitoring treatment of multiple sclerosis: concerted action guidelines. J Neurol Neurosurg Psychiatry 54:683-688
16. Andersson JH, Square S (2002) A model-based method for retrospective correction of geometric distortions in diffusion-weighted EPI. Neuroimage 16:177-199
17. Ni H, Kavcic V, Zhu T et al (2006) Effects of number of diffusion gradient directions on derived diffusion tensor imaging indices in human brain. AJNR 27:1776-1781 (Pubitemid 44413571)
18. Gupta RK, Saksena S, Hanson KM et al (2006) Focal Wallerian degeneration of the corpus callosum in large middle cerebral artery stroke: serial diffusion tensor imaging. J Magn Reson Imaging 24:549-555 (Pubitemid 44320556)
19. Agosta F, Absinta M, Sormani MP et al (2007) In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain 130:2211-2219 (Pubitemid 47236613)
20. Filippi M, Yousry T, Campi A et al (1996) Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 46:379-384 (Pubitemid 26081317)
21. Thompson AJ, Kermode AG, MacManus DG et al (1990) Patterns of disease activity in MS: clinical and MRI study. Br Med J 300:631-634
22. Matusevicius D, Navikas V, Söderström M et al (1996) Multiple sclerosis: the proinflammatory cytokines lymphotoxin-α and tumour necrosis factor-α are upregulated in cerebrospinal fluid mononuclear cells. J Neuroimmunol 66:115-123 (Pubitemid 26193944)
23. Aboitiz F, Scheibel AB, Fisher RS et al (1992) Fiber composition of the human corpus callosum. Brain Res 598:143-153 (Pubitemid 23013055)
24. Schmierer K, Altmann DR, Kassim N et al (2004) Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Mult Scler 10:182-187 (Pubitemid 38499912)
25. Cassol E, Ibarrola D, Ranjeva JP et al (2004) Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter. Mult Scler 10:188-196 (Pubitemid 38499913)
26. Tubridy N, Coles AJ, Molyneux P et al (1998) Secondary progressive MS: the relationship between short-term MRI activity and clinical features. Brain 121:225-231 (Pubitemid 28075799)
27. Barkhof F, Held U, Simon JH et al (2005) Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials. Neurology 65:1447-1454 (Pubitemid 41552778)
28. Evangelou N, Esiri MM, Smith S et al (2000) Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 47:391-395 (Pubitemid 30141854)
29. Evangelou N, Konz D, Esiri MM et al (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123:1845-1849 (Pubitemid 30664287)
30. Bjartmar C, Wuiek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165-171 (Pubitemid 36143722)
31. Uysal E, Erturk SM, Yildirim H et al (2007) Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. AJR Am J Roentgenol 188:697-702